Roche LumiraDx NT-proBNP test

• Precise results with lab-quality accuracy
• For rapid NT-proBNP measurement in 12 minutes using the LumiraDx point-of-care diagnostic system
• Supports the diagnosis of congestive heart failure
• Low sample volume – only 20 µl of blood required
• Quantitative results from fingerstick, whole blood, and plasma

The LumiraDx NT-proBNP test is used for the quantitative determination of NT-proBNP from capillary blood, venous lithium heparin whole blood, and lithium heparin plasma. This in vitro diagnostic test is intended for patients aged 18 years and older and supports healthcare professionals in the diagnosis of suspected congestive heart failure. As a point-of-care test, it provides accurate results from a fingerstick sample within 12 minutes. Multiple integrated quality controls ensure reliable and accurate performance of this microfluidic immunofluorescence test.

Product details

• Suitable for patients aged 18 and over
• Parameter: NT-proBNP (N-terminal pro-Brain Natriuretic Peptide)
• Detection: quantitative
• Test method: microfluidic immunoassay
• Sample types: capillary blood (fingerstick), venous whole blood (lithium heparin), plasma (lithium heparin)
• Measurement time: 12 minutes
• Medical specialties: general medicine, internal medicine, cardiology, laboratory medicine
• Country of origin: UK

Technical specifications

• Reference ranges:
• Heart failure unlikely: <125 ng/l
• Heart failure possible: ≥125 ng/l
• Sample volume: 20 µl
• Measuring range: 50–9,000 pg/ml (ng/l)
• Storage temperature: 2–30 °C
• Operating temperature: 15–30 °C

Package contents

• 12 Roche LumiraDx NT-proBNP tests